CVKD
NASDAQ · Pharmaceuticals

Cadrenal Therapeutics Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks
$6.52
-0.45 (-6.46%)
As of Mar 22, 10:57 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +160.0% upside
Low Target $12.65
Average Target $16.95
High Target $22.59
Current Price $6.52
Current
$6.52
Target
$16.95
$12.65 $16.95 avg $22.59
Scenario Analysis
Bear Case
$12.65
94.0%
Low target
Base Case
$16.95
+160.0%
Avg target
Bull Case
$22.59
+246.5%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$20.14
-67.6% from high
52-Week Low
$4.91
+32.8% from low
Target vs 52W High
$16.95
-15.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%